MX374074B - Composicion que comprende un extracto purificado que se aisla de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir o tratar enfermedad pulmonar obstructiva cronica y su uso. - Google Patents

Composicion que comprende un extracto purificado que se aisla de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir o tratar enfermedad pulmonar obstructiva cronica y su uso.

Info

Publication number
MX374074B
MX374074B MX2015008538A MX2015008538A MX374074B MX 374074 B MX374074 B MX 374074B MX 2015008538 A MX2015008538 A MX 2015008538A MX 2015008538 A MX2015008538 A MX 2015008538A MX 374074 B MX374074 B MX 374074B
Authority
MX
Mexico
Prior art keywords
active ingredient
isolated
preventing
pulmonary disease
chronic obstructive
Prior art date
Application number
MX2015008538A
Other languages
English (en)
Other versions
MX2015008538A (es
Inventor
Kyung Seop Ahn
Doo-Young Kim
Seung Hyung Kim
Ok-Kyoung Kwon
Suui Lee
Hyeongkyu Lee
Yongnam Lee
Sei Ryang Oh
Byung-Hwan Ryoo
In Sik Shin
Dae-Hee Shin
Hyuk-Hwan Song
Ji-Seok Yoo
Original Assignee
Yungjin Pharmaceutical Co Ltd
Korea Res Inst Bioscience & Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yungjin Pharmaceutical Co Ltd, Korea Res Inst Bioscience & Biotechnology filed Critical Yungjin Pharmaceutical Co Ltd
Publication of MX2015008538A publication Critical patent/MX2015008538A/es
Publication of MX374074B publication Critical patent/MX374074B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/55—Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición que comprende un extracto purificado que se aísla a partir de Pseudolysimachion rotundum var. subintegrum que contiene una abundante cantidad de ingrediente activo o los compuestos que se aislan de este como un ingrediente activo para prevenir o tratar una enfermedad pulmonar obstructiva crónica y el uso de los mismos. Los compuestos y el extracto purificado de la invención mostraron una actividad anti-COPD potente sin respuesta agonista del receptor beta-2 a través de diversas pruebas in vivo así como también pruebas in vitro. Por lo tanto, se pueden utilizar como el alimento para la salud o terapéutica para el tratamiento y prevención de la enfermedad pulmonar obstructiva crónica (COPD).
MX2015008538A 2013-04-10 2014-04-09 Composicion que comprende un extracto purificado que se aisla de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir o tratar enfermedad pulmonar obstructiva cronica y su uso. MX374074B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20130039458 2013-04-10
KR1020140036245A KR101476095B1 (ko) 2013-04-10 2014-03-27 고함량의 카탈폴 유도체를 다량 함유한 산꼬리풀 유래 꼬리풀 신규 정제물 또는 이로부터 분리된 카탈폴 유도체를 유효성분으로 포함하는 만성 폐쇄성 폐질환의 예방 또는 치료용 조성물
PCT/KR2014/003080 WO2014168413A1 (en) 2013-04-10 2014-04-09 The composition comprising a purified extract isolated from pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for preventing or treating chronic obstructive pulmonary disease and the use thereof

Publications (2)

Publication Number Publication Date
MX2015008538A MX2015008538A (es) 2016-04-15
MX374074B true MX374074B (es) 2025-03-05

Family

ID=51993687

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018015217A MX386593B (es) 2013-04-10 2014-04-09 Composicion que comprende un verprosido como ingrediente activo para prevenir o tratar una enfermedad pulmonar obstructiva cronica y su uso
MX2015008538A MX374074B (es) 2013-04-10 2014-04-09 Composicion que comprende un extracto purificado que se aisla de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir o tratar enfermedad pulmonar obstructiva cronica y su uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018015217A MX386593B (es) 2013-04-10 2014-04-09 Composicion que comprende un verprosido como ingrediente activo para prevenir o tratar una enfermedad pulmonar obstructiva cronica y su uso

Country Status (14)

Country Link
US (2) US9655871B2 (es)
EP (2) EP3019182B1 (es)
JP (1) JP5982077B2 (es)
KR (1) KR101476095B1 (es)
CN (1) CN105120880B (es)
AU (1) AU2014251492B2 (es)
BR (1) BR112015025595A2 (es)
CA (2) CA2905356C (es)
EC (1) ECSP15025868A (es)
ES (1) ES2728548T3 (es)
MX (2) MX386593B (es)
PL (1) PL3019182T3 (es)
RU (1) RU2594061C1 (es)
WO (1) WO2014168413A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101476095B1 (ko) 2013-04-10 2014-12-23 영진약품공업주식회사 고함량의 카탈폴 유도체를 다량 함유한 산꼬리풀 유래 꼬리풀 신규 정제물 또는 이로부터 분리된 카탈폴 유도체를 유효성분으로 포함하는 만성 폐쇄성 폐질환의 예방 또는 치료용 조성물
BR112023021369A2 (pt) * 2021-04-24 2024-01-02 Sava Healthcare Ltd Composição farmacêutica para tratar neutropenia, método e uso
CN115554286A (zh) * 2022-11-17 2023-01-03 云南养瑞科技集团有限公司 咖啡酸衍生物在制备治疗慢性阻塞性肺病药物中的应用
KR102849917B1 (ko) * 2022-12-30 2025-08-25 대구한의대학교산학협력단 베프로시드를 함유하는 골관절염 개선용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100349590C (zh) * 2004-07-02 2007-11-21 罗何生 地黄茎叶及其提取物抗哮喘和抗过敏的医药用途
KR100860080B1 (ko) 2005-05-30 2008-09-24 한국생명공학연구원 항염, 항알레르기 및 항천식 활성을 갖는 꼬리풀속 식물추출물을 함유하는 약학조성물
KR20060125499A (ko) 2005-05-30 2006-12-06 한국생명공학연구원 항염, 항알레르기 및 항천식 활성을 갖는 긴산꼬리풀추출물로부터 분리된 카탈폴 유도체를 함유하는 약학조성물
ES2368255T3 (es) 2005-05-30 2011-11-15 Korea Research Institute Of Bioscience And Biotechnology Composición farmacéutica que comprende un extracto de pseudolysimachion longifolium y los derivados de catapol aislados a partir de este, que tiene actividad antiinflamatoria, antialergica y antiasmática.
KR101476045B1 (ko) * 2012-12-31 2014-12-23 영진약품공업주식회사 활성성분을 다량 함유한 산꼬리풀 정제 분획물 (atc2), 이의 제조방법 및 이를 유효성분으로 포함하는 염증, 알레르기 및 천식의 예방 또는 치료용 조성물
KR101476095B1 (ko) 2013-04-10 2014-12-23 영진약품공업주식회사 고함량의 카탈폴 유도체를 다량 함유한 산꼬리풀 유래 꼬리풀 신규 정제물 또는 이로부터 분리된 카탈폴 유도체를 유효성분으로 포함하는 만성 폐쇄성 폐질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
EP3019182A1 (en) 2016-05-18
CA2957180C (en) 2019-10-15
WO2014168413A1 (en) 2014-10-16
CA2905356A1 (en) 2014-10-16
US20170266142A1 (en) 2017-09-21
JP2016516783A (ja) 2016-06-09
BR112015025595A2 (pt) 2017-07-18
MX386593B (es) 2025-03-19
US10172816B2 (en) 2019-01-08
CN105120880B (zh) 2017-06-13
CA2905356C (en) 2018-05-22
AU2014251492B2 (en) 2018-12-06
ES2728548T3 (es) 2019-10-25
EP3586859A1 (en) 2020-01-01
KR101476095B1 (ko) 2014-12-23
CN105120880A (zh) 2015-12-02
KR20140122656A (ko) 2014-10-20
US9655871B2 (en) 2017-05-23
EP3019182B1 (en) 2019-03-13
US20160051612A1 (en) 2016-02-25
AU2014251492A1 (en) 2015-11-12
RU2594061C1 (ru) 2016-08-10
PL3019182T3 (pl) 2019-09-30
EP3019182A4 (en) 2016-09-28
ECSP15025868A (es) 2016-01-29
JP5982077B2 (ja) 2016-08-31
MX2015008538A (es) 2016-04-15
CA2957180A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CO2017011851A2 (es) Compuestos novedosos
CL2018001031A1 (es) Inhibidores de ferroportina novedosos
UA113440C2 (xx) Сполуки тетрагідропіразолопіримідину
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
CU20170077A7 (es) Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos, composiciones y combinaciones que lo comprende
ECSP12012270A (es) Compuestos de pirazol como inhibidores del receptor sigma
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
CL2015000956A1 (es) Compuestos derivados de pirrolotriazinona como inhibidores de pi3k; composicion farmaceutica que los comprende; combinacion farmaceutica; uso para tratar enfermedades respiratorias, autoinmunes, trastornos neurologicos, cardiovasculares, metabolicos, entre otros.
CL2016001543A1 (es) Derivados del isocromeno como inhibidores de las fosfoinositido-3 quinasas.
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
EA201690888A1 (ru) Новые гетероциклические соединения
CR20150440A (es) Nuevos derivados de piridina
BR112016011170A8 (pt) derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica
BR112018011525A2 (pt) inibidores da tirosina quinase de bruton e métodos de seu uso
DOP2016000007A (es) Pirazolpiridinas sustituidas
PH12015502118A1 (en) Pyridin-4-yl derivatives
MX391620B (es) Formulaciones del inhibidor del antígeno-1 asociado a la función de linfocitos (lfa-1).
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
UY35848A (es) Tienopirimidinas
JOP20200100A1 (ar) مشتقات بيرازولو-بيرولو-بيريميدين-ديون جديدة كمثبِّطات لـ p2x3
CY1121238T1 (el) Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
MX374074B (es) Composicion que comprende un extracto purificado que se aisla de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir o tratar enfermedad pulmonar obstructiva cronica y su uso.
IN2013MU03773A (es)

Legal Events

Date Code Title Description
FG Grant or registration